Synopsys Company Profile (NASDAQ:SNPS)

Synopsys trades on the NASDAQ under the ticker symbol "SNPS."

Synopsys announced that its board has authorized a share repurchase program on Saturday, June 17th 2017, which allows the company to repurchase $500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy up to 4.5% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company's leadership believes its stock is undervalued.

Synopsys, Inc. (NASDAQ:SNPS) announced its quarterly earnings data on Wednesday, May, 17th. The company reported $0.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.02. The company earned $680.07 million during the quarter, compared to analyst estimates of $672.40 million. Synopsys had a return on equity of 11.16% and a net margin of 10.74%. The business's quarterly revenue was up 12.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.81 EPS. View Synopsys' Earnings History.

Synopsys is scheduled to release their next quarterly earnings announcement on Tuesday, August, 15th 2017. View Earnings Estimates for Synopsys.

Synopsys issued an update on its FY17 earnings guidance on Wednesday, May, 17th. The company provided EPS guidance of $3.24-3.29 for the period, compared to the Thomson Reuters consensus estimate of $3.25. The company issued revenue guidance of $2.65-2.67 billion, compared to the consensus revenue estimate of $2.60 billion.Synopsys also updated its Q3 guidance to $0.91-0.94 EPS.

9 brokerages have issued 1 year target prices for Synopsys' stock. Their predictions range from $60.00 to $87.00. On average, they expect Synopsys' share price to reach $76.50 in the next year. View Analyst Ratings for Synopsys.

Here are some recent quotes from research analysts about Synopsys stock:

• 1. According to Zacks Investment Research, "Synopsys is a vendor of electronic design automation (EDA) software to the semiconductor and electronics industries. We believe the company’s recent product launches, acquisitions and deal wins will boost results, going ahead. Moreover, unique intellectual properties and global support provided by the company will likely drive its forthcoming results. Additionally, the acquisition of Cigital and Codiscope will enable Synopsys to offer a comprehensive software security signoff solution to its customers. Notably, shares of Synopsys has outperformed the broader market over the past one year. However, competition from peers, a challenging technology spending environment and uncertainty regarding the exact time of realizing acquisition synergies keep us cautious." (5/16/2017)
• 2. Royal Bank Of Canada analysts commented, "Synopsys reported a solid quarter raising its full year guidance and generating 26.9% operating margins (highest margin profile since July 2009). In addition, the top line suggests 7%+ growth for the full year which should sustain double digit EPS growth' Synopsys reported upside to both the top and bottom line and generated operating margins of 26.9% which was the highest level since Jul-09 (over 7 years ago). While the full year numbers were only slightly modified (+$10M to both the low-end and highend) we think the margin profiles showcased the long-term potential for Synopsys. As the company continues to see revenues grow over the next several years, margins should expand in lock-step after digesting a set of acquisitions (Coverity then Cigital/Codiscope). With fundamentals continuing to improve we also highlight a solid cash balance sheet that can be utilized for continued share repurchases and strategic acquisitions as well. Net Net: the long-term potential for Synopsys continues to improve and we raise our price target to $77 (from $66)." (2/16/2017)

Synopsys saw a drop in short interest in June. As of June 30th, there was short interest totalling 1,823,567 shares, a drop of 40.0% from the June 15th total of 3,040,749 shares. Based on an average trading volume of 1,018,469 shares, the short-interest ratio is currently 1.8 days. Currently, 1.2% of the shares of the company are sold short.

Some companies that are related to Synopsys include Red Hat (RHT), Citrix Systems (CTXS), Cadence Design Systems (CDNS), Atlassian Corporation PLC (TEAM), Splunk (SPLK), SS&C Technologies Holdings (SSNC), The Ultimate Software Group (ULTI), Tyler Technologies (TYL), National Instruments Corporation (NATI), Micro Focus International plc (MCRO), Nuance Communications (NUAN), Nice Systems (NICE), Blackbaud (BLKB), Solera Holdings (SLH), Playtech PLC (PTEC), FireEye (FEYE), CommVault Systems (CVLT) and Paylocity Holding Corporation (PCTY).

Synopsys' management team includes the folowing people:

• Aart J. de Geus, Chairman of the Board, Co-Chief Executive Officer
• Chi-Foon Chan, President, Co-Chief Executive Officer, Director
• Trac Pham, Chief Financial Officer
• Joseph W. Logan, Executive Vice President - Worldwide Sales and Corporate Marketing
• John F. Runkel Jr., General Counsel and Corporate Secretary
• Steven C. Walske, Lead Independent Director
• Janice Durbin Chaffin, Independent Director
• Bruce R. Chizen, Independent Director
• Deborah A. Coleman, Independent Director
• Mercedes Johnson, Independent Director

Synopsys' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Swedbank (1.39%), Congress Asset Management Co. MA (0.70%), Acadian Asset Management LLC (0.68%), Russell Investments Group Ltd. (0.50%), PGGM Investments (0.36%) and Ardevora Asset Management LLP (0.34%). Company insiders that own Synopsys stock include Alfred Castino, Brian M Beattie, Chi-Foon Chan, Deborah A Coleman, Geus Aart De, John F Runkel Jr, John Schwarz, Joseph W Logan, Steven Walske, Sudhindra Kankanwadi and Trac Pham. View Institutional Ownership Trends for Synopsys.

Synopsys' stock was sold by a variety of institutional investors in the last quarter, including PGGM Investments, Acadian Asset Management LLC, APG Asset Management N.V., Great West Life Assurance Co. Can, Rothschild Asset Management Inc., Shell Asset Management Co., First Quadrant L P CA and AMI Asset Management Corp. Company insiders that have sold Synopsys stock in the last year include Alfred Castino, Brian M Beattie, Chi-Foon Chan, Geus Aart De, John F Runkel Jr, John Schwarz, Joseph W Logan, Steven Walske, Sudhindra Kankanwadi and Trac Pham. View Insider Buying and Selling for Synopsys.

Synopsys' stock was acquired by a variety of institutional investors in the last quarter, including Swedbank, Russell Investments Group Ltd., Congress Asset Management Co. MA, Wealth Enhancement Advisory Services LLC, Mn Services Vermogensbeheer B.V., Ardevora Asset Management LLP, First Citizens Bank & Trust Co. and Aperio Group LLC. View Insider Buying and Selling for Synopsys.

Shares of Synopsys can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Synopsys stock can currently be purchased for approximately $76.36.